However, no studies of the effects of SIL on glucose-stimulated insulin secretion (GSIS) have been reported previously, nor have other mechanisms involving the β-cell been clearly identified to explain the pharmacologic action(s) of SIL that decease elevated levels of fasting glucose and HbA1c in T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.